Home › Pathophysiology › Hemorrhagic Syndrome

Hemorrhagic Syndrome

Q: Which diseases are classified as hereditary vasopathies?

Hereditary vasopathies include hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease), or hereditary hemorrhagic angiopathy. In literature, it is classified as a hereditary angiopathy manifesting with multiple telangiectasias and hemorrhagic syndrome.

*Syndromum haemorrhagicum*

For medical students2 min readUpdated 2026-10-10

Hemorrhagic syndrome is a pathological condition characterized by a tendency toward increased bleeding. It develops due to profound disorders in the hemostatic system leading to hypocoagulation, and can be either genetically determined or acquired over the lifespan.

Core PathologyTendency toward bleeding due to a shift in hemostasis toward hypocoagulation.

Primary FormsAlways caused by genetically determined alterations of cells or plasma proteins.

Dangerous ComplicationAcute disseminated intravascular coagulation (DIC) is a severe example of multi-factorial hemostatic failure.

Main MechanismDecreased procoagulant activity coupled with an excess of anticoagulants and fibrinolytics.

Classification by Origin: Genetics vs Environment

In pathophysiology, hemorrhagic syndrome is viewed as a complex disorder of the hemostatic system. Fundamentally, all etiological factors are divided into two major groups based on their origin: hereditary (primary) and acquired.

Primary forms are always caused by genetically determined changes. This means the pathology is encoded at the DNA level and inherited. Genetic defects can affect various links of the coagulation system:

Vascular link: structural or functional anomalies of the vascular wall itself.
Cellular link: genetically determined defects affecting megakaryocytes and the platelets derived from them.
Plasma link: mutations leading to deficiencies or abnormalities of plasma adhesive proteins, as well as clotting factors of the coagulation system directly.

Acquired Forms: Targets and Damaging Factors

Unlike genetically determined forms, acquired hemorrhagic pathologies develop during the course of life and are driven by primary damage to initially healthy elements of the hemostatic system.

One of the main targets is the blood vessel walls. Their damage manifests as a pathological increase in permeability. This condition can have various etiologies:

Immunogenic — when vessels are damaged as a result of aberrant immune reactions.
Toxic-infectious — endothelial damage caused by microbial toxins during severe infections.
Dysmetabolic — structural vessel damage resulting from global metabolic disorders.

In addition to vessels, acquired lesions frequently target megakaryocytes and platelets, clinically manifesting as thrombocytopathies. Secondary damage to the pool of plasma adhesive proteins and coagulation factors is also possible. A separate category consists of multifactorial disorders, a classic example being acute DIC syndrome, where all links of hemostasis are simultaneously and fulminantly impaired.

Pathogenesis of Hypocoagulation: Four Main Mechanisms

Regardless of whether the pathology is congenital or acquired, the development of hemorrhagic syndrome is based on a shift in the blood balance toward hypocoagulation (reduced clotting). Four primary pathophysiological mechanisms lead to this condition:

Decreased content of procoagulants in the blood. There is a physical reduction in the concentration of proteins and factors required to form a blood clot.
Insufficient generation of activated procoagulants. Even if the baseline amount of clotting factors is normal, their conversion into the active form may be blocked, making it impossible to trigger the coagulation cascade.
Elevated content and/or excessive activation of anticoagulants. The anticoagulant system begins to work overly intensively, suppressing any attempts by the body to form a stable thrombus.
Increased content and/or excessive activation of fibrinolytics. The fibrinolytic system, which normally dissolves old clots, becomes pathologically overactive, destroying even those clots that are vital for stopping bleeding.

Mnemonic

To quickly memorize the four mechanisms of hypocoagulation, use the rule "Two P's and Two A's/F": decreased Procoagulant quantity, decreased Procoagulant activation; increased Anticoagulant activity, increased Fibrinolytic activity.

Frequently asked questions

Which specific diseases belong to hereditary defects of the plasma hemostatic link?

Hereditary defects of the plasma hemostatic link include hereditary coagulopathies associated with clotting factor deficiencies.

Hemophilia A — factor VIII deficiency.
Hemophilia B — factor IX deficiency.
von Willebrand disease — one of the most common hereditary coagulopathies associated with components of factor VIII; also described as a combined defect with factor VIII:W deficiency and plasma hemostasis impairment.
Rare bleeding disorders — hereditary deficiencies or abnormalities of fibrinogen, prothrombin (factor II), and factors V, VII, X, XI, XII, and XIII.

Which diseases are classified as hereditary vasopathies?

Hereditary vasopathies include hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease), or hereditary hemorrhagic angiopathy. In literature, it is classified as a hereditary angiopathy manifesting with multiple telangiectasias and hemorrhagic syndrome.

What is the fundamental difference between primary and acquired hemorrhagic syndrome?

Primary forms are always genetically determined and associated with congenital defects of cells or proteins. Acquired forms arise secondarily due to immunogenic, toxic-infectious, or dysmetabolic damage to an initially healthy hemostatic system.

What changes in the vascular wall lead to bleeding in acquired forms?

The primary cause is a pathological increase in vascular permeability resulting from toxic-infectious, immunogenic, or dysmetabolic insults to the vessels.

What is acute DIC syndrome in this context?

Acute DIC syndrome is considered a classic example of an acquired multifactorial hemostatic disorder, where complex disruptions lead to severe hemorrhagic manifestations.

How do anticoagulants and fibrinolytics behave during the development of hypocoagulation?

Their concentration in the blood increases, and their activity becomes excessively high. This blocks clotting processes and enhances clot dissolution, causing uncontrolled bleeding.

Go deeper

Genetic mutations determining megakaryocyte and platelet pathologies.
Mechanisms of immunogenic and toxic-infectious damage to blood vessel walls.
Dysmetabolic factors increasing vascular permeability.
The role of plasma adhesive proteins in primary hemostasis.
Pathogenesis of acute DIC syndrome as a multifactorial disorder.
Classification of hemorrhagic syndromes based on specific pathological entities.